BIAF bioAffinity Technologies, Inc.
$3.14▲ +6.08%
Healthcare
Other
After hours
$3.10▼ -1.27%
Oct 28, 5:00 PM ET
Volume 55.1K
Avg Volume (10D) 118.7K
Key Metrics & Fundamentals
Market Cap
$4.03M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.66 - 80.70
% vs 50 MA
-49.98%
% vs 200 MA
-83.82%
RSI-14
35.5
MACD Histogram
-0.0100
Beta (1Y vs SPY)
2.57
Free Cash Flow
-$3.29M
Gross Rev
$1.51M
Gross Profit
$422,742
EBITDA
-$3.29M
COGS
$1.09M
Operating Exp
$3.76M
Operating Income
-$3.33M
EBIT
-$3.33M
Pretax Income
-$3.37M
Net Income
-$3.37M
EPS (Diluted)
-9.60
Price & Volume History
Loading chart…
Recent News
bioAffinity Technologies to Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026
Business Wire · Oct 15, 2026 8:00 AM ET
bioAffinity Technologies to Present Positive Research Data in Development of Its New Test Measuring Asthma and COPD-Related Lung Inflammation and Drug-Related Receptors at CHEST 2026
Business Wire · Oct 13, 2026 8:00 AM ET
WallachBeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
PR Newswire · Oct 9, 2026 12:30 PM ET
BioAffinity Technologies Closes $4 Million Direct Offering, Private Placement
MT Newswires · Oct 9, 2026 12:13 PM ET
bioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Business Wire · Oct 9, 2026 11:37 AM ET
WallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
PR Newswire · Oct 8, 2026 1:30 PM ET
Update: BioAffinity Technologies Prices $4 Million Registered Direct Offering
MT Newswires · Oct 8, 2026 12:55 PM ET
BioAffinity Technologies Prices $4 Million Registered Direct Offering
MT Newswires · Oct 8, 2026 12:52 PM ET
bioAffinity Technologies, Inc. Announces Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Business Wire · Oct 8, 2026 12:07 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See BIAF's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.